---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025598"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:29:50.134066+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma shareholders authorize capital reduction, elect directors, reject officer liability amendment

## Summary
- Shareholders approved reducing authorized capital to 100M common + 1M preferred shares; amendment effective June 27, 2024.
- Six directors elected: Roger Kornberg, Phillip Frost, Fred Hassan, Anthony Japour, Richard Pfenniger, Steven Rubin.
- Weinberg & Company ratified as independent auditor for fiscal year ending December 31, 2024.
- Proposal to limit officer liability failed (4.85M for, 338K against; abstentions 26,484).
- Non-binding advisory vote on exec compensation approved; company will hold say-on-pay vote every three years.

## SEC filing metadata
- accession: 0001493152-24-025598
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000149315224025598/0001493152-24-025598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000149315224025598/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025598
- JSON: https://secwatch.observer/filing/0001493152-24-025598.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025598.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.